.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Baxter
Colorcon
Chubb
US Department of Justice
Teva
QuintilesIMS
US Army
Deloitte
Accenture

Generated: July 23, 2017

DrugPatentWatch Database Preview

Pharmacia And Upjohn Company Profile

« Back to Dashboard

What is the competitive landscape for PHARMACIA AND UPJOHN, and what generic alternatives to PHARMACIA AND UPJOHN drugs are available?

PHARMACIA AND UPJOHN has one hundred and thirty-six approved drugs.

There are nine US patents protecting PHARMACIA AND UPJOHN drugs.

There are two hundred and nine patent family members on PHARMACIA AND UPJOHN drugs in forty-five countries.

Summary for Applicant: Pharmacia And Upjohn

Patents:9
Tradenames:110
Ingredients:85
NDAs:136
Drug Master File Entries: (click here to view)41
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
GENOTROPIN PRESERVATIVE FREE
somatropin recombinant
INJECTABLE;INJECTION020280-011Jan 27, 1998RXYesNo► Subscribe► Subscribe
Pharmacia And Upjohn
GENOTROPIN PRESERVATIVE FREE
somatropin recombinant
INJECTABLE;INJECTION020280-001Jan 27, 1998RXYesNo6,152,897► SubscribeY ► Subscribe
Pharmacia And Upjohn
NEO-CORTEF
hydrocortisone acetate; neomycin sulfate
OINTMENT;TOPICAL060751-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pharmacia And Upjohn
XANAX
alprazolam
TABLET;ORAL018276-003Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
Pharmacia And Upjohn
CAVERJECT
alprostadil
INJECTABLE;INJECTION020379-004May 19, 1997APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Pharmacia And Upjohn

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
DETROL LA
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL021228-002Dec 22, 20005,559,269*PED► Subscribe
Pharmacia And Upjohn
DETROL LA
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL021228-001Dec 22, 20005,382,600*PED► Subscribe
Pharmacia And Upjohn
GENOTROPIN PRESERVATIVE FREE
somatropin recombinant
INJECTABLE;INJECTION020280-004Aug 24, 19954,968,299► Subscribe
Pharmacia And Upjohn
SOMAVERT
pegvisomant
INJECTABLE;SUBCUTANEOUS021106-002Mar 25, 20035,958,879► Subscribe
Pharmacia And Upjohn
GENOTROPIN PRESERVATIVE FREE
somatropin recombinant
INJECTABLE;INJECTION020280-009Jan 27, 19985,435,076► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for PHARMACIA AND UPJOHN drugs

Drugname Dosage Strength Tradename Submissiondate
linezolid
Injection2 mg/mL, 100 mL bag
ZYVOX
12/29/2009
linezolid
Injection2 mg/mL, 300 mL bag
ZYVOX
9/1/2009
linezolid
Oral Suspension100 mg/5 mL
ZYVOX
8/3/2009
tolterodine tartrate
Extended-release Capsules2 mg and 4 mg
DETROL LA
7/30/2007
linezolid
Tablets600 mg
ZYVOX
12/21/2005
colestipol hydrochloride
Tablets1 g
COLESTID
8/23/2005

Non-Orange Book Patents for Pharmacia And Upjohn

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,004,931 Method for inhibiting growth hormone action► Subscribe
6,451,561 Growth hormone variants► Subscribe
5,780,279 Method of selection of proteolytic cleavage sites by directed evolution and phagemid display► Subscribe
6,444,813 Linezolid-crystal form II► Subscribe
5,821,047 Monovalent phage display► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Pharmacia And Upjohn Drugs

Country Document Number Estimated Expiration
Slovenia1255754► Subscribe
World Intellectual Property Organization (WIPO)0110407► Subscribe
Austria412413► Subscribe
World Intellectual Property Organization (WIPO)0170225► Subscribe
Austria313316► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Pharmacia And Upjohn Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
60031Netherlands► SubscribePRODUCT NAME: DOXORUBICINESULFAAT VERKREGEN UIT DOXORUBICINEHYDROCHLORIDE EN AMMONIUMSULFAAT; REGISTRATION NO/DATE: EU/1/96/011/001 - EU/1/96/011/002 19960621
C0128France► SubscribePRODUCT NAME: LATANOPROST; REGISTRATION NO/DATE IN FRANCE: NL 22549 DU 19970724; REGISTRATION NO/DATE AT EEC: 12716 DU 19960718
C/GB09/026United Kingdom► SubscribePRODUCT NAME: ESTRADIOL AND COMBINATIONS OF ESTRADIOL AND DIENOGEST, PREFERABLY ESTRADIOL VALERATE AND COMBINATIONS OF ESTRADIOL VALERATE AND DIENOGEST; REGISTERED: BE BE 327792 20081103; UK PL 00010/0576-0001 20081208
2009 00017Denmark► SubscribePRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629
401Luxembourg► SubscribePRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Chinese Patent Office
UBS
Merck
Mallinckrodt
Federal Trade Commission
Cantor Fitzgerald
Covington
Farmers Insurance
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot